IOC Announces New Global Hospitality Model From Paris 2024 Onwards, “On Location” Appointed as Global Hospitality Provider Through to LA28
2.6.2021 13:45:00 EEST | Business Wire | Press release
The International Olympic Committee (IOC) today announced that the IOC, the International Paralympic Committee (IPC), and the Organising Committees of the Olympic Games and Paralympic Games (OCOGs) Paris 2024, Milano Cortina 2026 and LA28 will together introduce a new global hospitality model.
Fans and stakeholders will have access to unique ticket-inclusive travel and hospitality experiences through one, official, exclusive hospitality provider. To support this global hospitality programme, following a multi-stage selection process, On Location, a leader in the experiential hospitality business, has been appointed as the exclusive service provider for the Olympic and Paralympic Games Paris 2024, Milano Cortina 2026 and LA28 hospitality programmes. Working together with the Organising Committees, On Location will deliver world-class hospitality experiences for fans and Olympic stakeholders alike, with packages including tickets, travel, accommodation and unique in-venue and host city hospitality.
The new model will also enhance services for athletes’ families and friends wanting to see their loved ones compete at the Games, with support for travel, access to accommodation, and other services, including dedicated ticket inventory.
IOC President Thomas Bach said: “One of the recommendations of Olympic Agenda 2020+5 is to deliver additional turnkey solutions that could be provided to OCOGs to simplify the delivery complexity of the Games. This new solution will deliver a simplified, secure process for fans around the world to attend the Games. The centralisation of the project also contributes greatly to better oversight and, with this, to good governance. It will also directly support the staging of the Olympic and Paralympic Games, all the National Olympic Committees and most importantly their athletes.”
Tony Estanguet, President of Paris 2024, said: “Paris 2024 will be the first Olympic and Paralympic Games Organising Committee to propose a worldwide hospitality offer. This represents a fantastic opportunity – for us and the entire Paris 2024 ecosystem. Our teams are already at work and we look forward to innovating together, to offer unique hospitality experiences that will appeal to a broad global audience. In developing these new products, we will seek to showcase the best of French ‘art de vivre’, our gastronomy, art, culture, sport and innovation against the magnificent backdrop of the City of Lights, while fully respecting the focus on legacy at the heart of our vision.”
CONI and Milano Cortina 2026 President Giovanni Malagò said: “The new approach to hospitality, adopted by the IOC in line with Olympic Agenda 2020+5, is an important step for the entire Olympic and Paralympic Movement. It will provide a unique experience to our fans and stakeholders around the world, along with an important revenue stream that will help Milano Cortina 2026 to deliver exciting and sustainable Games. This agreement also shows how attractive the Italian Winter Games are at a global level and how great an opportunity they represent for our tourism industry and territories.”
LA28 Chairperson Casey Wasserman said: “On Location brings an incredible track record creating experiences for major global events, and will set a new standard for Olympic and Paralympic Games hospitality. Modernising the hospitality and ticketing platform has been a major priority for us as we prepare to host a world-class event in Los Angeles. This partnership furthers our commitment to deliver an extraordinary Games experience for athletes and fans in our community and around the world.”
On Location President Paul Caine said: “At On Location, we are dedicated to providing our customers with exceptional live event experiences that produce memories to last a lifetime. We are honoured to join the International Olympic Committee in reimagining hospitality at future Olympic and Paralympic Games, and we are committed to providing stakeholders, partners and fans around the globe with exclusive hospitality experiences that uniquely celebrate each host city.”
For a first look at On Location’s approach to hospitality at future Games, visit: www.onlocationexp.com/olympics
The IOC has facilitated this long-term agreement, working in collaboration with the Organising Committees of the Olympic and Paralympic Games Paris 2024, Milano Cortina 2026 and LA28. The Organising Committees and the National Olympic Committees (NOCs) and their Olympic teams will be the primary beneficiaries of the revenue generated through this new centralised approach, which will support the staging of the Olympic and Paralympic Games, the Olympic teams around the world and their athletes.
The reform is part of the Olympic Agenda 2020+5 vision to deliver long-term turnkey solutions that are provided over several editions of the Olympic Games with the aim of simplifying operations and driving efficiency in delivery, as well as driving new revenue sources.
In addition, and separate to the agreement with On Location, a new, integrated approach regarding global ticket sales will also be introduced from Paris 2024 onwards. It will provide secure, seamless access to Olympic and Paralympic tickets directly via each Organising Committee at standardised prices for each Games for fans in all corners of the world.
About the International Olympic Committee
The International Olympic Committee is a not-for-profit, civil, non-governmental, international organisation made up of volunteers which is committed to building a better world through sport. It redistributes more than 90 per cent of its income to the wider sporting movement, which means that every day the equivalent of USD 3.4 million goes to help athletes and sports organisations at all levels around the world.
For more information, please contact the IOC Media Relations Team:
Tel: +41 21 621 6000, email: pressoffice@olympic.org, or visit www.olympics.com
About On Location
On Location is a global leader in premium experiential hospitality, offering ticketing, curated guest experiences, live event production and travel management across sports, entertainment, fashion and culture. On Location provides unrivalled access for corporate clients and fans looking for official, immersive experiences at marquee events, including the Olympic and Paralympic Games, Super Bowl, NCAA Final Four, New York Fashion Week and more. An official partner and/or service provider to over 150 iconic rights holders, such as the IOC (Paris 2024, Milano Cortina 2026, LA28), NFL, NCAA, UFC and PGA of America, and numerous musical artists and festivals, the company also owns and operates a number of its own unique experiences. On Location is a subsidiary of Endeavor (NYSE:EDR), a global entertainment, sports and content company.
Broadcast quality footage
The IOC Newsroom: http://iocnewsroom.com/
Videos
YouTube: www.youtube.com/iocmedia
Photos
For an extensive selection of photos available shortly after each event, please follow us on Flickr.
To request archive photos and footage, please contact our Images team at: images@olympic.org
Social media
For up-to-the-minute information on the IOC and regular updates, please follow us on Twitter, Facebook and YouTube.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210602005305/en/
Contact information
On Location Media Contact:
Kim Ulrich | kulrich@endeavorco.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
